Insight journal, Insight journal - Deals and alliances

Q2 Partnering and Licensing Pharma trends of 2014

Posted on 01 August 2014

Tags: , ,

July 2014

By Raveena Bhambra

Q2 was full of deals, coupled with the talk of potential deals, and overall it finished on a high with a large volume of agreements coming together in June.

Key findings

  • Over 500 partnership deals announced during Q2
  • Four deals valued at over $1billion
  • The leading therapy deal of the quarter was a partnership focused on Crohn’s disease
  • Pfizer was the most active big pharma dealmaker

The following article is a summary of the key partnership deal pharma trends of Q2 covering highest value deals, top industry and therapy deals. We also look at the top five deals by headline value during the period and display their details, plus links to each full deal record are supplied by our proprietary deals and alliances database Current Agreements.


Premium content locked

Premium content

The remaining part of this article is Premium content – see below for access options.

Purchase this article

$35.00 BUY NOW

For $35.00, purchase this 3,095-word article and receive immediate online access.
100% Satisfaction Guarantee.

View a sample article

Already a subscriber?

Access to this area requires a CP Insight subscription.

Login for complete access

Subscription options

View for more information on pricing

Have a question?

Contact us

Related

Report: Bigpharma Deals and Alliances of 2013

Report: Merger and Acquisition Deals and Alliances of 2013

Browse: Complete Current Partnering report catalog

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Current Partnering

Current Partnering provides industry executives with partnering best practice and essential business intelligence. Further details about the range of reports and subscription services offered can be found at our website:

www.currentpartnering.com

This article was published July 2014.

For inquiries about the content of this article, please contact:

Email:                    enquiry@currentpartnering.com

 

Mail:                      Current Partnering

Wildwood Ventures Ltd

Allanmere House

6 Hobgate

York

YO24 4HF

United Kingdom

 

All rights reserved.

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif